CPT Code 76981 Fibroscan Results by Age Decade
CPT 76981 covers Fibroscan liver stiffness testing. See normal kPa ranges by age decade and how F2, F3, and cirrhosis thresholds apply to you.
16 source-based articles maintained by the HealthRX.com Editorial Team.

Showing 16 of 16 clinical reviews.
CPT 76981 covers Fibroscan liver stiffness testing. See normal kPa ranges by age decade and how F2, F3, and cirrhosis thresholds apply to you.
What can lower liver stiffness over time, what can temporarily change a FibroScan reading, and how current MASLD treatments fit into an evidence-based plan.
FibroScan uses vibration-controlled transient elastography (VCTE) to measure liver stiffness and steatosis. Learn what the results mean, normal ranges, and how scores guide MASLD staging and treatment decisions.
A clinical guide to vibration-controlled transient elastography (VCTE / FibroScan), covering when to order the test, how to interpret results, normal ranges, and its role in MASLD staging and treatment decisions.
How aerobic exercise, resistance training, and weight loss affect FibroScan (VCTE) liver stiffness and CAP scores. Includes normal ranges, MASLD staging cutoffs, and clinical guidance.
Can you get a FibroScan or VCTE result without a clinic visit? Learn about at-home liver stiffness proxies, finger-prick blood tests, normal VCTE ranges, and when formal FibroScan staging matters for MASLD and resmetirom eligibility.
Evidence-based FibroScan (VCTE) target ranges for longevity medicine, MASLD staging, and resmetirom eligibility. Board-reviewed clinical reference with primary literature citations.
How to interpret Fibroscan (VCTE) liver stiffness and CAP changes on GLP-1 agonists, resmetirom, SGLT2 inhibitors, and older MASLD drugs, including normal ranges, staging thresholds, and what a falling number does and does not prove.
A guide to interpreting Fibroscan / VCTE liver stiffness measurements, rate-of-change benchmarks, MASLD staging cutoffs, and resmetirom prescribing criteria, with primary-source citations throughout.
A guide to every drug class that falsely raises or lowers Fibroscan (VCTE) liver stiffness readings, plus normal ranges, what high and low scores mean, and how to get an accurate result.
Board-reviewed guide to how food intake, fasting duration, alcohol, and diet quality affect FibroScan (VCTE) results, with normal ranges, optimal values, and clinical protocols for MASLD staging.
Understand the difference between standard reference ranges and functional optimal targets for Fibroscan (VCTE) liver stiffness and CAP scores, with clinical guidance on interpretation.
How biological sex, menstrual cycle phase, and hormone therapy affect FibroScan (VCTE) liver stiffness and CAP scores. Includes normal ranges, optimal targets, and clinical guidance for MASLD staging.
Your FibroScan (VCTE) result directly determines whether you qualify for resmetirom, how aggressively your metabolic risk factors are treated, and when you need a hepatologist. Learn what each kPa range means for your care plan.
A clinician-informed guide to the laboratory panels and imaging studies that pair with FibroScan (VCTE) for accurate MASLD staging, fibrosis tracking, and treatment decisions.
Learn what your FibroScan score means, how liver stiffness maps to fibrosis stages F0 through F4, what CAP scores reveal about steatosis, and when to act on abnormal results.

LegitScript certification
Verify HealthRX.comHealthRX.com is a platform connecting patients with independent licensed healthcare providers and pharmacies. Those providers deliver medical care and pharmacies dispense medication. Prescriptions are issued only when clinically appropriate. Payment does not guarantee a prescription.
Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Individual results vary.
Website information is educational and is not a substitute for personalized medical advice, diagnosis, or treatment. Consult your licensed healthcare provider.